This archive report was first published on 21 September 2021.
On September 21, 2021, Kenya's Ministry of Health reported 313 new COVID-19 cases, raising the total number of cases documented in the country since March 2020 to 246,956.
Health Cabinet Secretary Mutahi Kagwe announced the new cases, which were detected from a sample size of 7,034 tested in the last 24 hours, resulting in a positivity rate of 4.5 per cent.
Unfortunately, 13 patients succumbed to the virus, with one death occurring within 24 hours and 12 deaths identified through facility audits on various dates in September.
The new deaths pushed the total fatalities reported since March 2020 to 5,008.
According to Kagwe, 1,378 patients were admitted to various health facilities across the country, while 2,973 were under home-based care.
He also reported that 97 patients were in the Intensive Care Unit (ICU), with 64 on ventilatory support and 26 on supplemental oxygen, and 7 patients under observation.
Additionally, 498 patients were discharged after recovering from the virus, bringing the total number of recoveries to 238,448.
As of September 20, a total of 3,409,017 vaccines had been administered across the country, including 2,543,876 first doses and 865,141 fully vaccinated individuals.
The uptake of the second dose among those who received their first dose was reported at 34.0 per cent.
The Government aims to vaccinate a targeted population of 27,246,033.
Kenya is now deploying five different types of vaccines, including Sinopharm, which arrived from China on Saturday, in addition to Moderna, Astrazeneca, Johnson & Johnson, and Pfizer vaccines.
